Singapore:Â Otsuka Pharmaceutical and H Lundbeck's submission of a marketing authorization application (MAA) for the approval of aripiprazole depot formulation has been accepted by the European ...
Vía oral: se deben tomar los comprimidos bucodispersables o la solución oral como una alternativa a los comprimidos en pacientes que tengan dificultad para tragar. El comprimido bucodispersable se ...
La domanda da Lei posta richiede un'attenta valutazione clinica comprensiva dell'anamnesi e dello status psicopatologico attuale. Tuttavia, Le posso dire che non esistono linee guida consolidate o ...
Vía oral: se deben tomar los comprimidos bucodispersables o la solución oral como una alternativa a los comprimidos en pacientes que tengan dificultad para tragar. El comprimido bucodispersable se ...
La dose massima di Abilify orodispersibile può arrivare a 30 mg al giorno in alcune situazioni, ma l’aumento va valutato attentamente dal suo psichiatra in base al suo quadro clinico e alla ...
A long-acting version of aripiprazole injection with improved dosing frequency for treating schizophrenia and bipolar disorder has been introduced in Korea. The Ministry of Food and Drug Safety ...
Pharmac – Te Pātaka Whaioranga is widening access to seven medicines, benefitting an estimated 5,700 people within the first year of funding. The decision includes treatments for schizophrenia, low ...
Pharmac – Te Pātaka Whaioranga plans to widen access to seven medicines benefitting over 6,000 people within the first 12 months of funding. The proposal includes treatments for schizophrenia, low ...
The information on this page may no longer be accurate. If you have any questions, you can email us at media@pharmac.govt.nz Pharmac – Te Pātaka Whaioranga plans to widen access to seven medicines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results